Ucb Biopharma Srl

This study looks at the long-term safety of a drug called rozanolixizumab in children aged 2 and older with generalized myasthenia gravis, a condition that causes muscle weakness. Participants will receive additional 6-week treatment cycles. The goal is to monitor serious side ef…

This study tests whether bimekizumab works better than risankizumab for adults with active psoriatic arthritis (PsA) who haven't responded to standard treatments. About 684 participants will receive one of the two drugs and be monitored for joint and skin improvement. The main go…

This study tests a drug called certolizumab pegol in children aged 6 to 17 with moderate to severe plaque psoriasis. The goal is to see how the drug works in the body and check its safety. About 49 participants will receive the drug or a placebo. This is not a cure, but aims to c…

This study looks at the long-term safety and effectiveness of the drug zilucoplan for people with generalized myasthenia gravis, a chronic muscle weakness condition. About 200 participants who completed a prior zilucoplan study will receive the drug openly. The goal is to see if …

This study looks at the long-term safety of a daily injection called zilucoplan in children with a rare autoimmune disease that causes muscle weakness. Up to 8 children who completed a previous study will receive the drug for another 52 weeks. The goal is to monitor side effects …

This study tests whether the drug brivaracetam can stop absence seizures in children and young adults aged 2 to 25 with childhood or juvenile absence epilepsy. Participants receive either the drug or a placebo, and doctors measure seizure freedom using a 24-hour brain wave test. …

This study is for people aged 12 and older with epilepsy who have prolonged seizures. It tests the long-term safety of an inhaled medication called Staccato alprazolam. Participants and their caregivers will use the medication at home when a seizure starts. The goal is to see if …